Evaxion Biotech A/S
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma (NCT05309421) | Evaxion Biotech A/S | 2022-09-19 |
| Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1 (NCT04455503) | Evaxion Biotech A/S | 2020-07-13 |
Track Evaxion Biotech A/S automatically
Every clearance here is in the API, with alerts when new ones post.